Combination of a pd-1 antagonist and a 4-abb agonist for treating cancer
Номер патента: EP3102604A1
Опубликовано: 14-12-2016
Автор(ы): Craig Bennett Davis, Li Yan, Maria Theresa KOEHLER
Принадлежит: Merck Sharp and Dohme LLC, PFIZER INC
Опубликовано: 14-12-2016
Автор(ы): Craig Bennett Davis, Li Yan, Maria Theresa KOEHLER
Принадлежит: Merck Sharp and Dohme LLC, PFIZER INC
Реферат: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a selective 4-1 BB agonist, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-Ll.
COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER
Номер патента: US20170174773A1. Автор: Yan Li,Davis Craig Bennett,Koehler Maria Theresa. Владелец: . Дата публикации: 2017-06-22.